News Articles


New ctDNA reference materials for NGS

SeraCare Life Sciences is adding ct­DNA Complete and ctDNA Panels to its circulating tumor DNA portfolio of reference materials. These new materials expand the Seraseq product line to also cover copy number variations and accelerate single-gene and variant-focused testing.


SeraCare Life Sciences Announces Joe Bernardo as New Company Chairman

SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, today announced that Joe Bernardo has joined SeraCare’s board of directors in the role of Chairman. Mr. Bernardo is also an Operating Partner at Linden Capital Partners who are the equity investors behind SeraCare Life Sciences.


SeraCare Enhances Quality Control Software

To ensure the accuracy of patient testing results, clinical next-generation sequencing (NGS) labs must track metrics across their assay’s workflow to determine whether runs were within established limits.


CTCs Can Make Better Samples Than Biopsies

SeraCare Life Sciences features in Genetic Engineering & Biotechnology News: Think of cancer as criminal activity, and you'll understand the need to properly secure evidence from liquid biopsies.


New Products Posted to GenomeWeb

SeraCare Life Sciences has launched AccuPlex Zika Reference Material, which is designed to fast-track the development and validation of PCR-based Zika virus assays